Cas 874279-07-9,Piperazine, 1-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-4-[(2,4-dimethyl -5-oxazolyl)carbonyl]-

874279-07-9

Post Buying Request

Basic information

Product Name: Piperazine, 1-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-4-[(2,4-dimethyl -5-oxazolyl)carbonyl]-
Synonyms:
CAS NO:874279-07-9
Molecular Formula: C27H31N5O2
Molecular Weight: 457.575
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Piperazine, 1-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-4-[(2,4-dimethyl -5-oxazolyl)carbonyl]-(CAS DataBase Reference)
NIST Chemistry Reference: Piperazine, 1-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-4-[(2,4-dimethyl -5-oxazolyl)carbonyl]-(874279-07-9)
EPA Substance Registry System: Piperazine, 1-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-4-[(2,4-dimethyl -5-oxazolyl)carbonyl]-(874279-07-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 874279-07-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

874279-07-9 Suppliers

Recommended suppliers

874279-07-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 874279-07-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,2,7 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 874279-07:
(8*8)+(7*7)+(6*4)+(5*2)+(4*7)+(3*9)+(2*0)+(1*7)=209
209 % 10 = 9
So 874279-07-9 is a valid CAS Registry Number.

874279-07-9Upstream product

2510-37-4 2,4-dimethyl-oxazole-5-carboxylic acid

874279-07-9Downstream Products

874279-07-9Relevant academic research and scientific papers

Gonadotropin releasing hormone receptor antagonists

-

Page/Page column 22-23, (2010/02/15)

The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 874279-07-9